2004 DETECTION OF MIXTURES OF HEPATITIS C VIRUS (HCV) TYPES

2003 ANTIVIRAL ACTIVITY, PHARMACOKINETICS, AND TOLERABILITY OF AZD7295, A NOVEL NS5A INHIBITOR, IN A PLACEBO-CONTROLLED MULTIPLE ASCENDING DOSE STUDY IN HCV GENOTYPE 1 AND 3 PATIENTS E. Gane, G.R. Foster, J. Cianciara, C. Stedman, S. Ryder, M. Buti, E. Clark, D. Tait. Auckland City Hospital, Auckland, New Zealand; Queen Mary University of London, The Royal London Hospital, London, UK; Regional Hospital of Infectious Diseases, Warsaw, Poland; Christchurch Clinical Studies, Christchurch, New Zealand; Nottingham University Hospitals NHS Trust, Nottingham, UK; Hospital Universitario Valle Hebron, Barcelona, Spain; Arrow Therapeutics Ltd, London, UK E-mail: edgane@adhb.govt.nz